Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »
Pedestrians wearing or covering a face mask due to the COVID-19 pandemic will walk past an M&S (Marks and Spencer) store in central London on 20 July 2020. tolga akmen / Agence France-Presse / Getty Images Marks & Spencer, the iconic but struggling UK retailer, said on Tuesday that it …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »
Text size Spencer Platt / Getty Images Large pharmaceutical company Pfizer announced second-quarter financial results on Tuesday morning that exceeded Wall Street expectations, sending shares of around 3% in pre-trade. The company reported earnings of $ 0.78 per share, beating the FactSet consensus at $ 0.10 and the S&P Capital …
Read More »